Hosted on MSN1mon
A New 'Missile' Drug Is Approved To Treat the Most Common Breast Cancer Type
The drug, called Datroway (datopotamab deruxtecan), is approved for patients who have already received endocrine-based therapy and chemotherapy. Datroway is part of a new class of medications ...
Pancreatic Cancer Action Network5d
FDA Approves New Treatment for PNETs: What You Need to Know
The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic ...
pharmaphorum1mon
Gilead buoyed by Trodelvy OK in new breast cancer use
On Friday, the FDA cleared Trodelvy (sacituzumab govitecan) for hormone receptor-positive, HER2-negative advanced breast cancer in patients who have received endocrine-based therapy and at least ...
European Drug Regulator Approves AstraZeneca's Two Flagship Cancer Drugs For Breast And Lung Cancer Settings
The EU approved AstraZeneca's Enhertu for certain breast cancer patients and Imfinzi for resectable NSCLC, showing ...
Precision Medicine Online1d
EC Approves AstraZeneca, Daiichi Sankyo's Enhertu in HER2-low, HER2-Ultralow Breast Cancer
The EC based its decision on data from the DESTINY-Breast06 trial, which included patients whose tumors had very low levels of HER2 expression.
pharmaphorum5mon
Roche gets FDA green light for breast cancer drug Itovebi
Itovebi (inavolisib) – one of a pair of new drugs reaching the market this ... whose cancer has progressed on or after endocrine-based therapy. It made $229 million in sales in the first six ...
Benzinga.com25d
Arvinas, Pfizer Breast Cancer Drug Fails To Show Progression-Free Survival Benefit In Trial
In February 2024, the U.S. Food and Drug Administration (FDA ... or metastatic breast cancer previously treated with endocrine-based therapy. Price Action: ARVN stock is down 52.4% at $8.35 ...
EU backs AstraZeneca, Daiichi's Enhertu for breast cancer treatment post endocrine therapy
The European Union's health regulator on Friday backed AstraZeneca and Daiichi Sankyo's drug Enhertu as a breast cancer treatment for patients who received endocrine therapy but are not suitable for ...
Verywell Health on MSN1y
Bioidentical Hormone Replacement Therapy: Is It Safe and Effective
Medically reviewed by Ana Maria Kausel, MD Bioidentical hormone replacement therapy (BHRT) treats hormonal imbalances in the ...
New York Post1mon
Drug commonly taken by older women linked to ‘worse Alzheimer’s outcomes’
Researchers from Mass General Brigham found that women treated with hormone ... Based on these findings, the team notes that women who have been menopausal for over 10 years without treatment ...
Cure Today25d
Vepdegestrant May Reduce Disease Progression in Breast Cancer Subset
In February 2024, the Food and Drug Administration granted fast track designation to vepdegestrant monotherapy for treating adults with ER+/HER2- advanced or metastatic breast cancer previously ...
MedPage Today10d
Breast Cancer: Factors Associated with Survival After CDK4/6 Inhibitor Therapy
According to a new study, visceral involvement and the duration of treatment with endocrine ... might offer comparable efficacy to endocrine-based treatments, with potentially better tolerability ...